Nuvation Bio (NUVB) Change in Cash (2020 - 2026)
Nuvation Bio (NUVB) posted quarterly Change in Cash of -$38.7 million for Q1 2026, down 415.77% year-over-year from $12.3 million in Q1 2025, and down 159.36% quarter-over-quarter from $65.2 million in Q4 2025.
Nuvation Bio (NUVB) Change in Cash (2020 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported Change in Cash for 7 consecutive years, with -$38.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash fell 415.77% year-over-year to -$38.7 million; the TTM figure through Mar 2026 stood at $77.4 million (up 474.84% YoY), while the FY2025 annual figure was $128.4 million, up 1953.35% from the prior year.
- Change in Cash slipped to -$38.7 million in Q1 2026 per NUVB's latest filing, from $65.2 million in the prior quarter.
- Across five years, Change in Cash topped out at $200.0 million in Q2 2025 and bottomed at -$149.1 million in Q3 2025.
- Historically, Change in Cash has averaged -$413647.1 across 5 years, with a median of -$3.9 million in 2022.
- On a YoY basis, Change in Cash climbed as much as 88985.78% in 2025 and fell as far as 3408.43% in 2025.
- Nuvation Bio's Change in Cash stood at -$37.6 million in 2022, then soared by 148.56% to $18.3 million in 2023, then slumped by 68.85% to $5.7 million in 2024, then surged by 1046.28% to $65.2 million in 2025, then slumped by 159.36% to -$38.7 million in 2026.
- Business Quant data shows NUVB's Change in Cash at -$38.7 million in Q1 2026, $65.2 million in Q4 2025, and -$149.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Nuvation Bio | 2.16 Bn | 2.16 Bn | 30.78 Mn | 133.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 133.21 Mn |
| Mar 31, 2026 | -38.70 Mn |
| Dec 31, 2025 | 65.19 Mn |
| Sep 30, 2025 | -149.07 Mn |
| Jun 30, 2025 | 199.99 Mn |
| Mar 31, 2025 | 12.25 Mn |
| Dec 31, 2024 | 5.69 Mn |
| Sep 30, 2024 | -4.25 Mn |
| Jun 30, 2024 | -225,000.00 |
| Mar 31, 2024 | -8.14 Mn |
| Dec 31, 2023 | 18.25 Mn |
| Sep 30, 2023 | -25.67 Mn |
| Jun 30, 2023 | 19.99 Mn |
| Mar 31, 2023 | -71.03 Mn |
| Dec 31, 2022 | -37.59 Mn |
| Sep 30, 2022 | 36.37 Mn |
| Jun 30, 2022 | -3.89 Mn |
| Mar 31, 2022 | -26.22 Mn |
| Dec 31, 2021 | -212.21 Mn |
| Sep 30, 2021 | -104.90 Mn |